• Skip to content
  • Jump to main navigation and login

Nav view search

Navigation

  • Home
  • WM Summits
  • WM Workshops

Search

You are here: Home Clinical Trials Current Trials

Welcome to the Bing Center

IMG_1111
Poster-Steve-Thea-3750
CC-g
DSC_6297
Kyle_Treon
528878861_wvTzn-X2-1
115_115
rny-sgm-1
photo_scan-3
DSCN0815
DSCN2926
527974038_6AEVg-X2-1
FPm-i
IMG_1174
527967728_DJVUG-X2-1
OrlandoSummitGroupPhoto
028_28
IMG_1424
nyc-sgm-3
Dr Steven Treon, IWMF & CO SGM leaders
LibraryImage18
Walter-Reed
start stop 
bwd fwd

About the Bing Center

  • About the Bing Center
  • Bing Center Staff
  • Media Gallery
  • Bing Center Clinic
  • Directions / Find Us
  • Contact Us

Resources

  • Home
  • Event Calendar
  • Clinical Trials
  • Basic Research
  • Publications
  • Bing Center News
  • Bing Center Spotlight
  • Related Web Links
  • How to Help

Current Trials

The clinical trials listed below are currently available at our clinic at the Dana-Farber Cancer Institute, as well as a number of our participating institutions:

Title
Phase 2: Carfilzomib, Rituximab, Dexamethasone (CaRD) in Waldenstrom's Macroglobulinemia.
Phase-2: LBH589 in Relapsed or Relapsed and Refractory Waldenstrom's Macroglobulinemia
Phase-1: Pomalidomide, Dexamethasone and Rituximab in Waldenstrom's Macroglobulinemia
Phase I/II Combination of Everolimus (RAD001), Rituximab (Rituxan) OR Everolimus, Bortezomib (VELCADE, PS-341) and Rituximab in Patients with Relapsed and/or Refractory Waldenstrom's Macroglobulinemia Based on Risk Stratification

Legal Statements  |  Privacy Policy

Powered by Interactive Eware